N. Brandon and A. Sawa, Linking neurodevelopmental and synaptic theories of mental illness through DISC1, Nature Reviews Neuroscience, vol.25, issue.12, pp.707-722, 2011.
DOI : 10.1038/nrn3120

P. Penzes, M. Cahill, K. Jones, J. Vanleeuwen, and K. Woolfrey, Dendritic spine pathology in neuropsychiatric disorders, Nature Neuroscience, vol.11, issue.3, pp.285-293, 2011.
DOI : 10.1038/nn.2583

D. Martins-de-souza, E. Dias-neto, and A. Schmitt, Proteome analysis of schizophrenia brain tissue, The World Journal of Biological Psychiatry, vol.14, issue.6, pp.110-120, 2010.
DOI : 10.1016/j.chroma.2009.01.063

K. Choi, M. Zepp, B. Higgs, C. Weickert, and M. Webster, Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development, J Psychiatry Neurosci, vol.34, pp.450-458, 2009.

M. Burmeister, M. Mcinnis, and S. Zöllner, Psychiatric genetics: progress amid controversy, Nature Reviews Genetics, vol.51, issue.7, pp.527-540, 2008.
DOI : 10.1038/nrg2381

J. Van-os, G. Kenis, and B. Rutten, The environment and schizophrenia, Nature, vol.65, issue.7321, pp.203-212, 2010.
DOI : 10.1038/nature09563

P. Brun, M. Bégou, and A. Andrieux, Dopaminergic transmission in STOP null mice, Journal of Neurochemistry, vol.65, issue.1, pp.63-73, 2005.
DOI : 10.1016/0165-0173(90)90015-G

URL : https://hal.archives-ouvertes.fr/inserm-00380189

M. Bégou, P. Brun, and J. Bertrand, Post-pubertal emergence of alterations in locomotor activity in stop null mice, Synapse, vol.177, issue.9, pp.689-697, 2007.
DOI : 10.1002/syn.20409

A. Andrieux, P. Salin, and M. Vernet, The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders, Genes & Development, vol.16, issue.18, pp.2350-2364, 2002.
DOI : 10.1101/gad.223302

M. Bégou, J. Volle, and J. Bertrand, The stop null mice model for schizophrenia displays cognitive and social deficits partly alleviated by neuroleptics, Neuroscience, vol.157, issue.1, pp.29-39, 2008.
DOI : 10.1016/j.neuroscience.2008.07.080

D. Delotterie, G. Ruiz, and J. Brocard, Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice, Psychopharmacology, vol.84, issue.1, pp.131-141, 2010.
DOI : 10.1007/s00213-009-1712-3

URL : https://hal.archives-ouvertes.fr/inserm-00447474

K. Powell, S. Hori, and R. Leslie, Cognitive impairments in the STOP null mouse model of schizophrenia., Behavioral Neuroscience, vol.121, issue.5, pp.826-835, 2007.
DOI : 10.1037/0735-7044.121.5.826

URL : https://hal.archives-ouvertes.fr/inserm-00380034

R. Fradley, O. Meara, G. Newman, R. Andrieux, A. Job et al., STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating, Behavioural Brain Research, vol.163, issue.2, pp.257-264, 2005.
DOI : 10.1016/j.bbr.2005.05.012

URL : https://hal.archives-ouvertes.fr/inserm-00380197

V. Fournet, J. M. Fabre, and V. , The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network, Journal of Neurochemistry, vol.12, issue.Suppl, pp.1579-1594, 2010.
DOI : 10.1111/j.1471-4159.2010.07064.x

URL : https://hal.archives-ouvertes.fr/inserm-00566974

C. Bouvrais-veret, S. Weiss, and N. Hanoun, Microtubuleassociated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission, J Neurochem, vol.104, pp.745-756, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00375628

E. Brenner, U. Sonnewald, A. Schweitzer, A. Andrieux, and A. Nehlig, Hypoglutamatergic activity in the STOP knockout mouse: A potential model for chronic untreated schizophrenia, Journal of Neuroscience Research, vol.18, issue.15, pp.3487-3493, 2007.
DOI : 10.1002/jnr.21200

URL : https://hal.archives-ouvertes.fr/inserm-00379976

C. Bouvrais-veret, S. Weiss, and A. Andrieux, Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice, Neuropharmacology, vol.52, issue.8, pp.1691-1700, 2007.
DOI : 10.1016/j.neuropharm.2007.03.015

URL : https://hal.archives-ouvertes.fr/inserm-00379958

A. Andrieux, P. Salin, and A. Schweitzer, Microtubule Stabilizer Ameliorates Synaptic Function and Behavior in a Mouse Model for Schizophrenia, Biological Psychiatry, vol.60, issue.11, pp.1224-1230, 2006.
DOI : 10.1016/j.biopsych.2006.03.048

URL : https://hal.archives-ouvertes.fr/inserm-00380045

S. Bhardwaj, M. Baharnoori, B. Sharif-askari, A. Kamath, S. Williams et al., Behavioral characterization of dysbindin-1 deficient sandy mice, Behavioural Brain Research, vol.197, issue.2, pp.435-441, 2009.
DOI : 10.1016/j.bbr.2008.10.011

D. Babovic, O. Tuathaigh, C. , O. Connor, and A. , Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous dele- tion of catechol-O-methyltransferase

O. Tuathaigh, C. Babovic, D. , O. Sullivan, and G. , Phenotypic characterization of spatial cognition and social behavior in mice with ???knockout??? of the schizophrenia risk gene neuregulin 1, Neuroscience, vol.147, issue.1, pp.18-27, 2007.
DOI : 10.1016/j.neuroscience.2007.03.051

T. Kato, A. Kasai, and M. Mizuno, Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1, PLoS ONE, vol.27, issue.1, p.14185, 2010.
DOI : 10.1371/journal.pone.0014185.s002

S. Eastwood, L. Lyon, L. George, A. Andrieux, D. Job et al., Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice, Journal of Psychopharmacology, vol.105, issue.6, pp.635-644, 2007.
DOI : 10.1177/0269881106068825

URL : https://hal.archives-ouvertes.fr/inserm-00380032

M. Galiano, C. Bosc, A. Schweitzer, A. Andrieux, D. Job et al., Astrocytes and oligodendrocytes express different STOP protein isoforms, Journal of Neuroscience Research, vol.19, issue.3, pp.329-337, 2004.
DOI : 10.1002/jnr.20260

A. Merenlender-wagner, R. Pikman, E. Giladi, A. Andrieux, and I. Gozes, NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse???A microtubule-deficient model of schizophrenia, Peptides, vol.31, issue.7, pp.1368-1373, 2010.
DOI : 10.1016/j.peptides.2010.04.011

URL : https://hal.archives-ouvertes.fr/inserm-00498115

B. Lipska and D. Weinberger, To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test, Neuropsychopharmacology, vol.23, issue.3, pp.223-239, 2000.
DOI : 10.1016/S0893-133X(00)00137-8

K. Benardais, B. Kasem, and A. Couegnas, Loss of STOP Protein Impairs Peripheral Olfactory Neurogenesis, PLoS ONE, vol.44, issue.9, p.12753, 2010.
DOI : 10.1371/journal.pone.0012753.g009

URL : https://hal.archives-ouvertes.fr/inserm-00566909

C. Bosc, J. Cronk, and F. Pirollet, Cloning, expression, and properties of the microtubule-stabilizing protein STOP., Proceedings of the National Academy of Sciences, vol.93, issue.5, pp.2125-2130, 1996.
DOI : 10.1073/pnas.93.5.2125

L. Guillaud, C. Bosc, and A. Fourest-lieuvin, STOP Proteins are Responsible for the High Degree of Microtubule Stabilization Observed in Neuronal Cells, The Journal of Cell Biology, vol.15, issue.1, pp.167-179, 1998.
DOI : 10.1083/jcb.133.1.151

K. Talbot, D. Cho, and W. Ong, Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin, Human Molecular Genetics, vol.15, issue.20, pp.3041-3054, 2006.
DOI : 10.1093/hmg/ddl246

K. Burdick, T. Lencz, and B. Funke, Genetic variation in DTNBP1 influences general cognitive ability, Human Molecular Genetics, vol.15, issue.10, pp.1563-1568, 2006.
DOI : 10.1093/hmg/ddi481

A. Fallgatter, M. Herrmann, and C. Hohoff, DTNBP1 (Dysbindin) Gene Variants Modulate Prefrontal Brain Function in Healthy Individuals, Neuropsychopharmacology, vol.43, issue.9, pp.2002-2010, 2006.
DOI : 10.1038/sj.npp.1301003

F. Papaleo, B. Lipska, and D. Weinberger, Mouse models of genetic effects on cognition: Relevance to schizophrenia, Neuropharmacology, vol.62, issue.3, pp.1204-1220, 2012.
DOI : 10.1016/j.neuropharm.2011.04.025

P. Schloss and T. Lau, STOP-in the name of mood: microtubule-associated proteins in mood and cognition, Journal of Neurochemistry, vol.60, issue.1, pp.1-3, 2012.
DOI : 10.1111/j.1471-4159.2011.07614.x

C. Lewis, D. Levinson, and L. Wise, Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia, The American Journal of Human Genetics, vol.73, issue.1, pp.34-48, 2003.
DOI : 10.1086/376549

H. Shimizu, Y. Iwayama, and K. Yamada, Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia, Schizophrenia Research, vol.84, issue.2-3, pp.244-252, 2006.
DOI : 10.1016/j.schres.2006.03.017

A. Thompson, C. Bartholomeusz, and A. Yung, Social cognition deficits and the ???ultra high risk??? for psychosis population: a review of literature, Early Intervention in Psychiatry, vol.185, issue.1, pp.192-202, 2011.
DOI : 10.1111/j.1751-7893.2011.00275.x

J. Brunelin, T. Amato, J. Van-os, A. Cochet, M. Suaud-chagny et al., Effects of acute metabolic stress on the